We use first and third-party cookies to offer our services and collect statistical data. If you continue browsing this website you accept their use. More information Accept


Lesvi's product portfolio comprises CNS pharmaceuticals and nutraceuticals, unique dosage forms and products in other therapeutic areas such as antiemetic, anti-infective, cardiovascular, diseases and pain. 
Product Indication Dosage form Strength
Clopidogrel Atherothrombosis Film-coated tablets 75 mg
Enalapril Hypertension Tablets 5 and 20 mg
Enalapril + HCTZ Hypertension Tablets 20/12.5 mg
Imidapril * Hypertension Tablets 5, 10 and 20 mg
Lisinopril Hypertension Tablets 5 and 20 mg
Lisinopril + HCTZ Hypertension Tablets 20/12.5 mg
Prasugrel Base Prophylaxis and therapy of thrombosis Film-coated tablets 5 and 10 mg
Rivaroxaban Thrombosis, stroke Film-coated tablets 10, 15 and 20 mg
Telmisartan Hypertension Tablets 20, 40 and 80 mg
Valsartan Hypertension Film-coated tablets 40, 80, 160 and 320 mg

[*] Differentiated product
[**] Opioid

Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain a Marketing Authorisation. In particular these products are under development for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, i.e. activities carried out to obtain a Marketing Authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.

© Neuraxpharm / LESVI. All rights reserved.